M&A Deal Summary |
|
---|---|
Date | 2012-10-29 |
Target | The Rugby Group |
Sector | Distribution |
Buyer(s) | The Harvard Drug Group |
Sellers(s) | Allergan |
Deal Type | Divestiture |
Deal Value | 117M USD |
SEARCH BY
Try For Free 7-Day Free Trial
The Harvard Drug Group LLC is a pharmaceutical distributor in the United States. Harvard Drug supplies generic and branded pharmaceuticals to over 6,000 retail customers, which include independent, regional and national pharmacies.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Distribution) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (California) | 1 of 1 |
Country (United States) | 2 of 2 |
Year (2012) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-08-03 |
Letco Med
Wayne, Pennsylvania, United States Letco Med provides turnkey solutions for pharmacies worldwide, specializing in respiratory and compounded, customized medications, as well as technology-driven diagnostics. Letco Med offers a suite of pharmacy operations consulting, compounding chemicals, equipment and supplies, pre-mix medications, and industrial facilities equipment. Letco Med is based in Wayne, Pennsylvania. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-02-02 |
Letco Med
Wayne, Pennsylvania, United States Letco Med provides turnkey solutions for pharmacies worldwide, specializing in respiratory and compounded, customized medications, as well as technology-driven diagnostics. Letco Med offers a suite of pharmacy operations consulting, compounding chemicals, equipment and supplies, pre-mix medications, and industrial facilities equipment. Letco Med is based in Wayne, Pennsylvania. |
Sell | $34M |
Category | Company |
---|---|
Founded | 1956 |
Sector | Life Science |
Employees | 31,200 |
Revenue | 15.8B USD (2018) |
Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.
DEAL STATS | # |
---|---|
Overall | 1 of 9 |
Sector (Distribution) | 1 of 2 |
Type (Divestiture) | 1 of 9 |
State (California) | 1 of 1 |
Country (United States) | 1 of 8 |
Year (2012) | 1 of 1 |
Size (of disclosed) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-04-25 |
Actavis Group
Zug, Switzerland Actavis is a generic pharmaceutical companies, specializing in the development, manufacture and sale of generic pharmaceuticals. The company has operations in more than 40 countries, with over 10,000 employees. At present, Actavis has a portfolio which includes more than 1,000 medicines present on the market and registered in more than 70 countries. |
Buy | €4.3B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-05-20 |
Warner Chilcott
Ardee, Ireland Warner Chilcott is a global specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. |
Buy | $8.5B |